Compugen
Develops and commercializes novel drug candidates for oncology and immunology.
About
Compugen is a clinical-stage drug discovery and development company focused on identifying and developing novel drug candidates for oncology and immunology. They utilize their proprietary discovery platforms to identify new biological targets and develop innovative therapies for unmet medical needs.
Key facts
At-a-glance profile data
- Website
- cgen.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 1993
- Employees
- 112
- Total funding
- $102M (Funding Round)
- Business model
- B2B
- Tags
- OncologyImmunologyLife SciencesBiotechMedTech
Funding rounds
| Date | Round | Amount | Post-money | Lead investors |
|---|---|---|---|---|
| 11 Nov 2021 | Funding Round | $20M | - | Bristol-Myers Squibb |
| 11 Oct 2018 | Funding Round | $12M | - | Bristol-Myers Squibb |
| 30 Dec 2009 | Undisclosed round | $20M | - | Cantor Fitzgerald |
| 12 Jul 2000 | Funding Round | $35M | $150M | - |
| 18 Dec 1998 | Undisclosed round | $15M | $55M | - |
Tech stack
Detected on cgen.com, last scanned 8 Sept 2026. Run your own scan
- CDN
- Cloudflare
- Email provider
- Microsoft 365
“Compugen Ltd. reported strong fourth quarter and full year 2025 financial results, driven by a $65 million non-dilutive royalty monetization deal with AstraZeneca that extends its cash runway into 2029.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
Frequently asked
How much funding has Compugen raised?
Compugen has raised a total of $102M in funding. The most recent round on record is Funding Round.
How many employees does Compugen have?
Compugen has approximately 112 people on record.